Iq-ai Share Discussion Threads

[festario] 27/12/2023 12:27

Both brokers will take 500k shares above the bid price, which is always encouraging.

[festario] 21/12/2023 08:58

Max to sell with both my brokers, = 0

[clocktower] 20/12/2023 15:32

Every dip is getting a little higher each time it seems F. Hopefully will hold onto it until the New Year.

[festario] 20/12/2023 13:49

You're right Clocky.I never, ever learn.The only way to make money on this or any stock is to sell into the spikes. Unfortunately, the next sell will have a 3 in front of it, which means we are no better off than before this latest RNS.

[festario] 20/12/2023 08:16

You can't sell a single share with either of my brokers this morning. Such a shame.

[howdlep] 20/12/2023 07:51

Here's a ChatGBT summary of the RNS (Regulatory News Service) announcement regarding IQ-AI Ltd's subsidiary, Imaging Biometrics (IB), and the implications of their recent FDA Fast-Track designation for oral gallium maltolate (GaM) in treating glioblastoma (GBM):

Summary of RNS:

Company Involved: Imaging Biometrics, LLC, a subsidiary of IQ-AI Ltd.
Announcement: The U.S. FDA has granted Fast-Track designation to IB's oral gallium maltolate (GaM) for treating adult patients with relapsed or refractory glioblastoma (GBM), IDH-wildtype.

Significance of FDA Decision: Reflects the urgency and unmet medical need in treating GBM. Oral GaM has also received Orphan Drug designation, highlighting its potential in addressing this critical area.

Benefits of Fast-Track Designation: Enables an accelerated review process with the FDA. This involves increased communication and collaboration, aimed at speeding up the development and approval process.

Company's Response: Trevor Brown, CEO of IQ-AI, expressed satisfaction with this milestone and emphasized commitment to working closely with the FDA to fast-track the clinical development of oral GaM.

Implications and Bullet Points:

Accelerated Development and Approval: Fast-Track designation means quicker development and potential approval of oral GaM, which could lead to faster patient access.

Addressing Unmet Medical Needs: GBM is a severe and currently underserved medical condition. This designation underlines the treatment's importance in filling a significant therapeutic gap.

Increased FDA Interaction: The designation allows for more frequent communication with the FDA, possibly leading to more efficient development processes.

Market Positioning: This milestone enhances the market positioning of IQ-AI and its subsidiary, potentially leading to commercial advantages.

Investor Confidence: Such regulatory milestones can positively impact investor confidence, reflecting the potential success and viability of the treatment.

Enhanced Corporate Reputation: Receiving Fast-Track status boosts the company's reputation in the biotech and pharmaceutical industry, potentially opening doors for future collaborations and investments.

[hatfullofsky] 19/12/2023 19:03

This will get some coverage tomorrow and still below £10m

[hatfullofsky] 19/12/2023 18:58

Now's not the time to get rid of EVG, wait for the news / excuses and then decide

[clocktower] 19/12/2023 18:19

hat.here before I set this thread up but over the years traded it. It used to be Flying Brands when TB took over, and before that Flying Flowers that also incorporated Stanley Gibbons. So it has a long history. :-)

Out of most at present - cash being king as far as I am concerned.

You never mentioned if you slung your hook with EVG?

Nice finish today here today, lets hope it heads for 7p very soon.

[spurs90] 19/12/2023 18:18

Fast Track Designation

The Fast Track Designation process helps to facilitate the development and expedite the review of new drugs that treat a serious medical condition and fill an unmet medical need. By speeding up these processes, new drugs can get to patients in need faster than they normally would through standard tracks.

Fast Track Designation is intended to address unmet medical needs and a wide range of serious conditions. A drug may be granted Fast Track Designation if it is believed to have an impact on patient survival, day-to-day functioning, or if it is believed that the condition will progress in severity if left untreated. Examples of serious conditions that treatment drugs may receive Fast Track Designation for include: AIDS, Alzheimer’s, heart failure, cancer, epilepsy, depression, and diabetes.

If a therapy already exists, Fast Track Designation may still be granted if it is believed a therapy will serve an unmet medical need by potentially being better than available therapies.

Drugs that receive Fast Track Designation from the FDA are eligible for some or all of the following benefits:

More frequent meetings with the FDA
More frequent written communication with the FDA
Eligibility for Accelerated Approval and Priority Review if criteria are met
Rolling review
Drug companies can request Fast Track Designation, and the request can occur any time during the drug development process. Upon receipt, the FDA will review the Fast Track Designation request and make a decision within 60 days. If granted, it is encouraged for drug companies to have frequent communication with the FDA to ensure questions and issues are resolved quickly so the drug can be approved soon and get to patients who would benefit from it.

[hatfullofsky] 19/12/2023 15:45

Hello Clock, How long have you been here ? I knew you were in BIRD but didn't know you were here

[clocktower] 19/12/2023 15:12

Good to see you here hat - have you sold the dog EVG yet?

[firestarter1] 19/12/2023 15:09

Brown can dump now

[firestarter1] 19/12/2023 15:09

More pumps of this dog

[hatfullofsky] 19/12/2023 15:04

Mid-afternoon RNS, won't be picked up by most commentators until tomorrow but sure this could rocket now. FDA Fast-Track after only 14 patients in Phase 1. That's special.

[bad gateway] 19/12/2023 14:58

Seems very good news. Does this help with their $100M claim/voucher too or is that dependent on other regulatory pathways still?

[festario] 19/12/2023 14:40

Merry Christmas Trev Lad!

[clocktower] 19/12/2023 14:36

Here we go, expect MM to play games.

[festario] 19/12/2023 14:34

Excellent.. correct steps being taken.

[clocktower] 19/12/2023 14:30

Super news of Fast Tracking.

[festario] 14/12/2023 09:34

Next news please Mr Brown, as promised in the RNS about regular updates. Something about contract renewals or new customers would be just dandy.